Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-06

FDA Approved: PIOGLITAZONE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Pioglitazone and Metformin Hydrochloride (Macleods Pharmaceuticals Limited). This fixed-dose combination product is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pioglitazone and Metformin Hydrochloride (Pioglitazone and metformin hydrochloride)

Snippet

SUPPL AP for PIOGLITAZONE AND METFORMIN HYDROCHLORIDE (PIOGLITAZONE AND METFORMIN HYDROCHLORIDE)